NCT00262808View on ClinicalTrials.gov

GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

sargramostim

DRUG

fluorouracil

DRUG

leucovorin calcium

DRUG

oxaliplatin

PROCEDURE

adjuvant therapy

PROCEDURE

conventional surgery

PROCEDURE

neoadjuvant therapy

Trial Locations (2)

14642

James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester

27710

Duke Comprehensive Cancer Center, Durham

All Listed Sponsors
lead

University of Rochester

OTHER

NCT00262808 - GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | Biotech Hunter | Biotech Hunter